Dr. Benkirane described his work, which identified a fraction of CD4 T lymphocytes in the viral reservoir through membrane expression of the CD32 molecule, and showed that a low-noise viral replicative cycle persists within these cells, making it impossible to suggest that the reservoir is entirely latent. This work opens up new prospects for the therapeutic targeting of these cells.
Speaker(s)
Monsef Benkirane
Institute of Human Genetics, CNRS, Montpellier